Chicago MS Alliance received a positive readout from the phase 3 remibrutinib trial for relapsing multiple sclerosis from Novartis.
Public source
Publisher name
Public post
Excellent news from Novartis showing a positive readout from the ph3 remibrutinib trial for relapsing #MS. Believe it or not this was the *first* phase 3 trial I was inv…
Company
Chicago MS Alliance
Dedicated to advancing MS and neuroimmunology care in the Chicago region.
- Industry
- Non-profit Organizations
- Location
- Chicago, US
- Company size
- 2–10 employees
About Chicago MS Alliance
The Chicago MS Alliance is a nonprofit network of multiple sclerosis (MS) centers and clinicians across Chicagoland, working together to improve access, education, and research. Our mission is to unify and amplify efforts across the region, creating opportunities for interdisciplinary collaboration, advancing clinical trial participation, and promoting equitable care for all people living with MS and related disorders. CMSA hosts events, patient education days, and professional development programs—serving as a connector between healthcare professionals, patients, and advocacy organizations. Visit us at chicago-ms.org to learn more, explore who we are, or join our email list for upcoming programs.
See moreLatest activity
Latest activity from Chicago MS Alliance
3 signals
Presence & Recognition
Chicago MS Alliance hosted a special program with Drs. Kavita Thakkar and Allison Osen discussing pediatric-onset and late-onset multiple sclerosis.
Presence & Recognition
Chicago MS Alliance announced the presence of Augusto Miravalle, Veronica Cipriani, Carolyn Goldschmidt, and Edie Graham at an event.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Neurology Center of New England - Foxboro
Neurology Center of New England - Foxboro participated in the Phase 3 REMODEL study evaluating remibrutinib in people living with relapsing multiple sclerosis (MS).
Research & Knowledge
Multiple Sclerosis Association of America (MSAA)
Multiple Sclerosis Association of America (MSAA) published an article by Chief Medical Officer Dr. Barry Hendin in the newest edition of the award-winning Ask the Expert series reviewing the different types of pain and potential treatment options for individuals living with multiple sclerosis.
Research & Knowledge
MS International Federation (MSIF)
MS International Federation (MSIF) published a new paper in Neurology exploring how the updated 2024 McDonald criteria can be implemented across diverse healthcare settings to support earlier diagnosis and avoid misdiagnosis.
Research & Knowledge
Novartis
Novartis shared positive topline results from two Phase III studies evaluating an investigational oral treatment for relapsing multiple sclerosis.
Research & Knowledge
National MS Society